BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 20637658)

  • 1. Type I interferons regulate cytolytic activity of memory CD8(+) T cells in the lung airways during respiratory virus challenge.
    Kohlmeier JE; Cookenham T; Roberts AD; Miller SC; Woodland DL
    Immunity; 2010 Jul; 33(1):96-105. PubMed ID: 20637658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonspecific recruitment of memory CD8+ T cells to the lung airways during respiratory virus infections.
    Ely KH; Cauley LS; Roberts AD; Brennan JW; Cookenham T; Woodland DL
    J Immunol; 2003 Feb; 170(3):1423-9. PubMed ID: 12538703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections.
    Hogan RJ; Usherwood EJ; Zhong W; Roberts AA; Dutton RW; Harmsen AG; Woodland DL
    J Immunol; 2001 Feb; 166(3):1813-22. PubMed ID: 11160228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airway-Resident Memory CD8 T Cells Provide Antigen-Specific Protection against Respiratory Virus Challenge through Rapid IFN-γ Production.
    McMaster SR; Wilson JJ; Wang H; Kohlmeier JE
    J Immunol; 2015 Jul; 195(1):203-9. PubMed ID: 26026054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung airway-surveilling CXCR3(hi) memory CD8(+) T cells are critical for protection against influenza A virus.
    Slütter B; Pewe LL; Kaech SM; Harty JT
    Immunity; 2013 Nov; 39(5):939-48. PubMed ID: 24238342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I interferon plays opposing roles in cytotoxicity and interferon-γ production by natural killer and CD8 T cells after influenza A virus infection in mice.
    Arimori Y; Nakamura R; Yamada H; Shibata K; Maeda N; Kase T; Yoshikai Y
    J Innate Immun; 2014; 6(4):456-66. PubMed ID: 24435166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renewal of peripheral CD8+ memory T cells during secondary viral infection of antibody-sufficient mice.
    Cauley LS; Cookenham T; Hogan RJ; Crowe SR; Woodland DL
    J Immunol; 2003 Jun; 170(11):5597-606. PubMed ID: 12759439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad4 promotes differentiation of effector and circulating memory CD8 T cells but is dispensable for tissue-resident memory CD8 T cells.
    Hu Y; Lee YT; Kaech SM; Garvy B; Cauley LS
    J Immunol; 2015 Mar; 194(5):2407-14. PubMed ID: 25637015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Airway epithelial versus immune cell Stat1 function for innate defense against respiratory viral infection.
    Shornick LP; Wells AG; Zhang Y; Patel AC; Huang G; Takami K; Sosa M; Shukla NA; Agapov E; Holtzman MJ
    J Immunol; 2008 Mar; 180(5):3319-28. PubMed ID: 18292557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I IFN signaling facilitates the development of IL-10-producing effector CD8
    Jiang L; Yao S; Huang S; Wright J; Braciale TJ; Sun J
    Eur J Immunol; 2016 Dec; 46(12):2778-2788. PubMed ID: 27701741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-independent antiviral function of memory CD4+ T cells in vivo requires regulatory signals from CD8+ effector T cells.
    Zhong W; Roberts AD; Woodland DL
    J Immunol; 2001 Aug; 167(3):1379-86. PubMed ID: 11466356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary antigen encounter regulates the establishment of tissue-resident CD8 memory T cells in the lung airways and parenchyma.
    McMaster SR; Wein AN; Dunbar PR; Hayward SL; Cartwright EK; Denning TL; Kohlmeier JE
    Mucosal Immunol; 2018 Jul; 11(4):1071-1078. PubMed ID: 29453412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granzyme B regulates antiviral CD8+ T cell responses.
    Salti SM; Hammelev EM; Grewal JL; Reddy ST; Zemple SJ; Grossman WJ; Grayson MH; Verbsky JW
    J Immunol; 2011 Dec; 187(12):6301-9. PubMed ID: 22084442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory impact of IFN-γ in CD8+ T cell-mediated lung injury is mediated by both Stat1-dependent and -independent pathways.
    Ramana CV; DeBerge MP; Kumar A; Alia CS; Durbin JE; Enelow RI
    Am J Physiol Lung Cell Mol Physiol; 2015 Apr; 308(7):L650-7. PubMed ID: 25617378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion.
    Hendriks J; Xiao Y; Rossen JW; van der Sluijs KF; Sugamura K; Ishii N; Borst J
    J Immunol; 2005 Aug; 175(3):1665-76. PubMed ID: 16034107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: effector memory CD8+ T cells in the lung airways retain the potential to mediate recall responses.
    Ely KH; Roberts AD; Woodland DL
    J Immunol; 2003 Oct; 171(7):3338-42. PubMed ID: 14500625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I interferons and MAVS signaling are necessary for tissue resident memory CD8+ T cell responses to RSV infection.
    Varese A; Nakawesi J; Farias A; Kirsebom FCM; Paulsen M; Nuriev R; Johansson C
    PLoS Pathog; 2022 Feb; 18(2):e1010272. PubMed ID: 35108347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza infection results in local expansion of memory CD8(+) T cells with antigen non-specific phenotype and function.
    Sckisel GD; Tietze JK; Zamora AE; Hsiao HH; Priest SO; Wilkins DE; Lanier LL; Blazar BR; Baumgarth N; Murphy WJ
    Clin Exp Immunol; 2014 Jan; 175(1):79-91. PubMed ID: 23937663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting edge: Antigen is not required for the activation and maintenance of virus-specific memory CD8+ T cells in the lung airways.
    Kohlmeier JE; Miller SC; Woodland DL
    J Immunol; 2007 Apr; 178(8):4721-5. PubMed ID: 17404250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling.
    Gracias DT; Stelekati E; Hope JL; Boesteanu AC; Doering TA; Norton J; Mueller YM; Fraietta JA; Wherry EJ; Turner M; Katsikis PD
    Nat Immunol; 2013 Jun; 14(6):593-602. PubMed ID: 23603793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.